http://aboutmicrocontroller.tradepub.com/?pt=cat&page=ALL Thu, 11 Jun 2026 08:20:21 -0700 Free trade magazines, white papers, downloads and podcasts for business professionals http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_spry01 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_spry01 Thu, 11 Jun 2026 07:50:11 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_spry01"><img src="http://img.tradepub.com/free/w_spry01/images/w_spry01c.gif" border=0></a></td><td valign=top><p>AI projects fail when they&rsquo;re approached like traditional software projects. Unlike standard IT initiatives, AI requires experimentation, strong data foundations, cross-functional collaboration, trust in outcomes, and continuous optimization. In this report, Spryfox breaks down why 67% of AI projects fail, what separates successful AI initiatives from the rest, and the practical steps organizations can take to improve delivery, reduce risk, and turn AI investment into measurable business value.&nbsp;</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_spry01">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_tear05 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_tear05 Thu, 11 Jun 2026 06:20:13 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_tear05"><img src="http://img.tradepub.com/free/w_tear05/images/w_tear05c.gif" border=0></a></td><td valign=top><p>Co-brand debit turns everyday spend into owned data, predictable interchange revenue, and deeper customer relationships, without relying on OTAs or seasonal bookings.</p> <p><u><strong>What you'll get from this report:&nbsp;</strong></u></p> <p><strong>The revenue case:</strong>&nbsp;&nbsp;Understand how interchange economics, reduced OTA dependence, and data-driven upsells create compounding returns across the customer lifecycle.<br /> <br /> <strong>A sector-by-sector breakdown:&nbsp;</strong>See how travel, hospitality, and retail brands each face distinct loyalty challenges, and how co-branded debit solves them differently for each.<br /> <br /> <strong>A launch roadmap you can act on:</strong>&nbsp;From auditing program gaps to selecting the right platform partner, get a practical framework for bringing a co-branded debit program to market.<br /> <br /> <em>By downloading this e-book, you agree you subscribe to Tearsheet</em></p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_tear05">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_fujj84 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_fujj84 Thu, 11 Jun 2026 05:21:19 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_fujj84"><img src="http://img.tradepub.com/free/w_fujj84/images/w_fujj84c.gif" border=0></a></td><td valign=top><p>Subcontracting Process Characterization (PC) can strengthen CMC submissions and streamline regulatory review when supported by deliberate planning in three areas: feed materials (representative, sufficient, stable, with options for intermediate-scale and worst‑case feeds), small‑scale models (risk‑based justification, ranges aligned to manufacturing capability, and compatibility with high‑throughput contractor equipment), and analytics (early CQA assignment, fit‑for‑purpose assay qualification, comprehensive sampling, and pre‑agreed statistical/reporting methods). With robust tech transfer and modular, parallel work packages, timelines can be compressed. Partnering with experienced providers&nbsp;can offer&nbsp;the expertise, tools, and workflows to minimize rework and enable a smooth transition through PPQ to licensure.&nbsp;This white paper offers concise, practical guidance for biopharma teams outsourcing Process Characterization (PC) to strengthen CMC packages and accelerate commercialization.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_fujj84">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_fujj80 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_fujj80 Thu, 11 Jun 2026 05:20:59 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_fujj80"><img src="http://img.tradepub.com/free/w_fujj80/images/w_fujj80c.gif" border=0></a></td><td valign=top><p>As cell and gene therapies accelerate toward the clinic, the pressure to translate early innovation into scalable, GMP-compliant viral vector manufacturing has never been greater. Yet for many sponsors, the path from bench to patient is complex, costly, and filled with risk. This article examines how strategic CDMO partnerships can transform that journey, streamlining development while safeguarding quality, timelines, and budgets.</p> <p>Whether leveraging platform processes or pursuing tailored development, the right CDMO partner brings not just capacity, but can unlock faster, more reliable pathways to clinical success.</p> <ul> <li><strong>Strategic process alignment:</strong> Choosing between platform adoption, tech transfer, or full development based on program needs</li> <li><strong>Phase-appropriate decision-making:</strong> Balancing speed, cost, and quality without compromising long-term success</li> <li><strong>Risk mitigation through early investment:</strong> Strengthening process and analytical development to avoid re-work and delays</li> <li><strong>Transparent partnerships:</strong> Building trust through proactive communication, data integrity, and shared accountability</li> <li><strong>Patient-centered execution:</strong> Recognizing that every delay impacts not just timelines, but lives</li> </ul> <p>For biotech and pharma companies navigating viral vector manufacturing this guide offers practical insights to de-risk development and maximize CDMO partner value, turning complexity into competitive advantage.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_fujj80">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_gamb13 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_gamb13 Thu, 11 Jun 2026 05:20:13 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_gamb13"><img src="http://img.tradepub.com/free/w_gamb13/images/w_gamb13c.gif" border=0></a></td><td valign=top><p>Disruption is inevitable. The speed and skill it takes to cause it just collapsed. AI removed the human limiter on both sides: attackers now turn fresh vulnerabilities into working exploitation with a fraction of the effort and expertise it used to require, and zero-days surface faster than any team can safely test and remediate. The patch model that held for a decade just expired.</p> <p>This session opens with Gambit&rsquo;s own threat-intelligence research on how fast this new normal is already advancing in the wild, and how little an adversary now needs to know to succeed. This lays the foundation for the rest of the discussion about the new strategy required to tackle the new normal: cyber resilience. When prevention cannot keep pace, continuous resilience becomes the discipline that matters. It comes down to one thing: how fast and how cleanly you get your mission-critical business capabilities back online when AI-powered attackers disrupt at a pace that defenders cannot sustain.</p> <p>Curtis Simpson, Chief Strategy Officer at Gambit Security, connects the research to what real, end-to-end recovery actually takes inside a complex hybrid environment, and why the tools most teams already own address only portions of the big problem.</p> <p>What you'll take away</p> <ul> <li>A current read on AI-armed attacker capability, with real data from Gambit's research on how fast exploitation now happens and how few people it takes.</li> <li>The metrics that actually define resilience: whether your mission-critical capabilities come back fast and clean, measured end to end.</li> <li>A clear map of where the recovery tools most teams own (IaC, backup, DR automation, posture dashboards) each fall short, so you find the gaps before an incident does.</li> </ul> <p><u><strong>Speakers</strong></u></p> <p><strong>Curtis Simpson</strong><br /> Chief Strategy Officer, Gambit Security<br /> Curtis Simpson is a proven executive leader with over 20 years of experience in business-focused security and technology executive roles at Fortune 100 enterprises, multi-billion dollar tech companies and security startups. He currently serves as Chief Strategy Officer at Gambit Security, where he acts as an extension of the founders&rsquo; team and leads strategy from both a technology and business perspective. Prior to joining Gambit Security as CSO, Curtis was the CISO, CIO and CAO at Armis and before that, he was the Global CISO at Sysco Foods. He has spoken at hundreds of live and virtual technology and leadership events around the globe.</p> <p><strong>Terry Sweeney</strong><br /> Moderator, Black Hat</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_gamb13">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_momf02 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_momf02 Thu, 11 Jun 2026 05:10:58 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_momf02"><img src="http://img.tradepub.com/free/w_momf02/images/w_momf02c.gif" border=0></a></td><td valign=top><p>Specialty therapies continue to drive growth in the pharmaceutical industry, with spending and treatment complexity increasing across rare and specialty disease categories. While scientific innovation has expanded treatment possibilities, the patient experience required to access and remain on therapy has become increasingly complex. Patients often encounter multiple barriers&mdash;including diagnosis delays, coverage challenges, affordability concerns, and fragmented coordination across providers, payers, pharmacies, HUBs, and support vendors.</p> <p>Despite significant investment in patient support infrastructure, many programs remain heavily focused on back-end access functions, leaving critical engagement needs unmet. As a result, patients may experience confusion, delays, abandonment, and early discontinuation that can affect both outcomes and therapy success.</p> <p>Industry stakeholders increasingly recognize that operational infrastructure alone is insufficient. Effective support requires a dedicated front-end engagement model that combines human connection, education, guidance, and proactive outreach to help patients and healthcare providers navigate complexity and maintain momentum throughout the treatment experience.</p> <p>This paper examines the factors contributing to patient journey breakdowns, the role of front-end engagement in addressing those challenges, the growing emphasis on patient experience as a strategic investment area, and the value of specialized engagement models designed to improve therapy initiation, persistence, and overall support experiences.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_momf02">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_allp53 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_allp53 Thu, 11 Jun 2026 05:10:13 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_allp53"><img src="http://img.tradepub.com/free/w_allp53/images/w_allp53c.gif" border=0></a></td><td valign=top><p>In this webinar, you will discover the results of our global survey of Small and Medium Sized Businesses (SMBs), in which we found trends, opinions and insights based on their relationship to protecting their businesses and their reputations from cyberthreats. We also dive into SMBs&rsquo; expectations from their telecom providers regarding cybersecurity services and what they are willing to pay for those services.</p> <p>OMDIA analyst Camille Mendler will join the morning session to present SMB market insights and her own take on the results of Allot's SMB Cybersecurity Survey.</p> <p>In the&nbsp;afternoon session, Bonnie Niederstrasser, Senior Manager, Network Embedded Security Products at Verizon will present a case study of Verizon's journey with Allot Secure for their small business customers.</p> <p>And finally, all participants in the webinar will be entitled to a 30 minute consulting session with an Allot cybersecurity services experts. Details will be provided during the webinar.</p> <p><strong>Speakers</strong>:&nbsp;</p> <p><strong>Armita Satari</strong>,&nbsp;Head of Custom Content, Telecoms.com</p> <p>As the Head of Custom Content, Armita leads the production of bespoke content on Telecoms.com Intelligence. Prior to joining the team, she held a number of roles at the GSMA, the mobile industry association, leading on strategic research and analytical output on mobile as an assistive technology and mobile networks and services. Before that, Armita was the primary industry Analyst specialising on the DACH region at Ovum (now Omdia), delivering business critical and intelligence research and consulting. She brings nigh onto seven years of analysis and research experience in the TMT sector.</p> <p><strong>Camille Mendler</strong>, Research Director, Omdia</p> <p>Camille Mendler has more than 25 years' multi-disciplinary experience in the digital economy and a global remit to anticipate key shifts in B2B demand patterns with a current focus on how 5G is disrupting enterprise ecosystems.</p> <p>Her consultancy projects solve go-to-market challenges: identifying buyer segments, creating effective value propositions, and determining sales channel mix. Areas of expertise include managed and professional services, cloud and SaaS, and private networks.</p> <p>During her tenure at Omdia, Camille has launched SoHo and SME and Enterprise Verticals intelligence services. She serves as a judge for the GSMA&rsquo;s GLOMO Awards and TM Forum&rsquo;s Excellence Awards.</p> <p>Camille has advised organizations including the International Telecommunications Union, Open Society Foundations and World Bank. She has also worked as a telecom contract negotiator, expert witness in dark fiber matters, and technology journalist.</p> <p>Camille won a research fellowship in Russian Area Studies from Georgetown University and holds a bachelor&rsquo;s degree in journalism and Russian from Northwestern University.</p> <p><strong>Francisco Cayuela Delgado</strong>, Cybersecurity Executive Director, Allot</p> <p>With over 20 years in the tech and telecom industries at Allot, Vodafone, and Nokia, Francisco brings deep expertise in building growth strategies and forging partnerships with some of the world&rsquo;s top operators. Since 2017, he has contributed to Allot&rsquo;s strategic shift toward cybersecurity, playing a central role in positioning the company as a leader in network-native security. Over the past two years, he has focused on helping Europe&rsquo;s leading telcos transform cybersecurity into revenue-generating services while making their networks safer, smarter, and more valuable.</p> <p><strong>Seth Greenberg</strong>, Director of Corporate Marketing, Allot</p> <p>Seth Greenberg is a seasoned marketing executive with over 20 years of international experience driving growth in the cybersecurity and telecommunications sectors. As Director of Corporate Marketing at Allot, he specializes in strategically positioning cybersecurity solutions for global tier-1 operators and their consumer and SMB customers.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_allp53">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_thbs214 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_thbs214 Thu, 11 Jun 2026 05:01:14 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_thbs214"><img src="http://img.tradepub.com/free/w_thbs214/images/w_thbs214c.gif" border=0></a></td><td valign=top><p>When scaling biologics from clinical to commercial production, biopharma companies face a difficult choice: invest in inflexible 10,000-15,000L stainless-steel systems that lock you into fixed capacity, or scale out with multiple 2,000L single-use bioreactors that increase complexity and costs. Both options waste resources&mdash;either through unused capacity or operational inefficiency.</p> <p>The 5,000L single-use bioreactor offers an ideal middle ground. It bridges the gap between small-scale flexibility and commercial-scale capacity, offering the agility to scale up or down as market demand shifts while eliminating the cleaning validation, changeover delays and capital commitment of stainless steel. For the 80% of biologics requiring less than 750 kg/year production, the 5,000L sweet spot matches actual market needs without over- or under-investing in capacity.</p> <p><strong>Download the white paper to discover:</strong></p> <ul> <li>Why volatile biopharma markets demand manufacturing flexibility that stainless steel can't provide</li> <li>How 5,000L single-use bioreactors deliver superior economics for products in the 30-150 kg/year demand range</li> <li>Real-world scale-up data showing consistent performance from 50L to 5,000L across multiple molecules</li> <li>How DynaDrive's 20:1 turndown ratio and enhanced mass transfer support both early clinical trials and commercial manufacturing</li> </ul><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_thbs214">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_twol01 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_twol01 Thu, 11 Jun 2026 04:30:23 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_twol01"><img src="http://img.tradepub.com/free/w_twol01/images/w_twol01c.gif" border=0></a></td><td valign=top><p>Biopharma teams are often forced to make high-stakes clinical and commercial decisions without timely access to external expert insight.</p> <p>Simulated Advisory Boards (SABs) provide a faster, more flexible way to generate expert-informed insights before committing to critical decisions.</p> <p>SABs enable&nbsp;teams to explore critical questions, test assumptions, and uncover risks earlier in the development and launch optimization process.</p> <p>In this white paper, you'll learn how to:&nbsp;</p> <ul> <li>Generate actionable insights in days &mdash; not months</li> <li>Pressure - test positioning, evidence strategy, and key assumptions</li> <li>Explore diverse clinician and stakeholder perspectives early</li> <li>Identify risks and gaps before live advisory board engagement</li> <li>Strengthen your advisory strategy with a hybrid approach</li> </ul> <p>Featuring a real-world case example, this paper shows how early simulation can reshape clinical, commercial, and access strategies,&nbsp;&mdash; helping teams move forward with greater clarity and confidence.</p> <p>Get the insights you need to make smarter decisions, faster.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_twol01">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_veea308 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_veea308 Thu, 11 Jun 2026 04:10:42 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_veea308"><img src="http://img.tradepub.com/free/w_veea308/images/w_veea308c.gif" border=0></a></td><td valign=top><p>As that footprint grows, recovery depends more on credential security. Relying only on native retention or app-specific tools can leave you with uneven coverage and inconsistent recovery across your SaaS environment.</p> <p>This buyer&rsquo;s guide covers real-world constraints (e.g., API limits, data sovereignty) and what to prioritize for predictable recovery.</p> <p>Download the guide and learn how to evaluate:</p> <ul> <li>Granular recovery: Item-level and record-level restores, metadata, and relationships.</li> <li>Recovery speed at scale: Bulk restores, monitoring, and API throttling.</li> <li>Compliance and legal readiness: Policy-based retention, audit trails, and defensible reporting.</li> <li>Centralized management: Visibility, consistent policies, and role-based administration across SaaS, identity, and cloud.</li> <li>Containing identity blast radius: Separation of duties, isolated admin paths, and controlled post-compromise recovery.</li> </ul><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_veea308">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_veea307 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_veea307 Thu, 11 Jun 2026 04:10:28 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_veea307"><img src="http://img.tradepub.com/free/w_veea307/images/w_veea307c.gif" border=0></a></td><td valign=top><p>Learn how Veeam brings together backup, recovery, monitoring, and cyber resilience in one unified solution, helping you protect, move, and recover data with confidence, while comparing Veeam&rsquo;s robust capabilities with industry competitors.</p> <p>From foundational capabilities to real world success stories, learn how Veeam delivers measurable business value everywhere your data lives.</p> <p>Inside, you&rsquo;ll learn:</p> <ul> <li>How Veeam goes beyond backup to deliver complete data resilience</li> <li>Veeam&rsquo;s positioning against competitors in key areas like cyber resilience and data portability</li> <li>The ways Veeam enables secure, efficient migrations across any environment&nbsp;</li> <li>Real world success stories of organizations accelerating recovery and maintaining control</li> </ul><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_veea307">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_veea306 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_veea306 Thu, 11 Jun 2026 04:10:13 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_veea306"><img src="http://img.tradepub.com/free/w_veea306/images/w_veea306c.gif" border=0></a></td><td valign=top><p>Available with Veeam Data Platform Premium Edition and co-developed with Coveware, Recon Scanner helps you stay ahead of ransomware and other threats. This proactive tool delivers behavior-based threat detection, continuous monitoring, and seamless integration with platforms like Microsoft Sentinel, so your team can quickly identify and mitigate risks before they escalate.</p> <p>Download this solution brief to learn how to:</p> <ul> <li>Proactively detect and respond to ransomware and suspicious activity with real-world, behavior-based intelligence.</li> <li>Integrate Recon Scanner into your existing security ecosystem for maximized protection and rapid incident response.</li> <li>Leverage actionable insights mapped to the MITRE ATT&amp;CK framework to strengthen your organization&rsquo;s data resilience.</li> </ul><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_veea306">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eurp34 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eurp34 Thu, 11 Jun 2026 00:02:10 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eurp34"><img src="http://img.tradepub.com/free/w_eurp34/images/w_eurp34c.gif" border=0></a></td><td valign=top><p>All 10 major economies saw real GDP growth downgrades and upward revisions to inflation for the year in our latest forecasts. Global expansion drops below 3% in 2026, while inflation rises above 4%&mdash;tightening demand and squeezing profitability.</p> <p>The Strait of Hormuz blockage is the defining shock of 2026. Disruption to this critical maritime corridor exposed the fragility of energy supply, pushing input costs higher and feeding through to transport, manufacturing and consumer prices. Margins are narrowing, and investment is coming under pressure.</p> <p>In this report, you get updated real GDP growth projections, inflation forecasts, scenarios and regional outlooks to help you prepare for shifts. Use these insights to inform strategic decisions and resource allocation.</p> <p><strong>How H2 is shaping up:</strong></p> <ul> <li><strong>Energy shock fallout</strong>: Rising costs ripple through supply chains and demand</li> <li><strong>Growth slows, inflation rises</strong>: Margin pressure intensifies</li> <li><strong>Across-the-board revisions</strong>: Weaker growth and higher inflation reset expectations</li> <li><strong>Exposure gaps</strong>: Which markets are at risk versus more resilient</li> <li><strong>Alternative scenarios</strong>: How conditions could unfold from here</li> </ul> <p><strong>What you&rsquo;ll find inside:</strong></p> <ul> <li>New Iran war scenarios that simulate potential outcomes</li> <li>Revised GDP growth projections across 11 economies</li> <li>Updated inflation forecasts<strong> </strong>across 11 economies</li> <li>Regional outlooks and risk analysis for the US, Eurozone, UK, China and ASEAN</li> </ul><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eurp34">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eurp33 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eurp33 Thu, 11 Jun 2026 00:01:50 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eurp33"><img src="http://img.tradepub.com/free/w_eurp33/images/w_eurp33c.gif" border=0></a></td><td valign=top><p>All 10 major economies saw real GDP growth downgrades and upward revisions to inflation for the year in our latest forecasts. Global expansion drops below 3% in 2026, while inflation rises above 4%&mdash;tightening demand and squeezing profitability.</p> <p>The Strait of Hormuz blockage is the defining shock of 2026. Disruption to this critical maritime corridor exposed the fragility of energy supply, pushing input costs higher and feeding through to transport, manufacturing and consumer prices. Margins are narrowing, and investment is coming under pressure.</p> <p>In this report, you get updated real GDP growth projections, inflation forecasts, scenarios and regional outlooks to help you prepare for shifts. Use these insights to inform strategic decisions and resource allocation.</p> <p><strong>How H2 is shaping up:</strong></p> <ul> <li><strong>Energy shock fallout</strong>: Rising costs ripple through supply chains and demand</li> <li><strong>Growth slows, inflation rises</strong>: Margin pressure intensifies</li> <li><strong>Across-the-board revisions</strong>: Weaker growth and higher inflation reset expectations</li> <li><strong>Exposure gaps</strong>: Which markets are at risk versus more resilient</li> <li><strong>Alternative scenarios</strong>: How conditions could unfold from here</li> </ul> <p><strong>What you&rsquo;ll find inside:</strong></p> <ul> <li>New Iran war scenarios that simulate potential outcomes</li> <li>Revised GDP growth projections across 11 economies</li> <li>Updated inflation forecasts<strong> </strong>across 11 economies</li> <li>Regional outlooks and risk analysis for the US, Eurozone, UK, China and ASEAN</li> </ul><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eurp33">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_shrm71 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_shrm71 Thu, 11 Jun 2026 00:01:32 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_shrm71"><img src="http://img.tradepub.com/free/w_shrm71/images/w_shrm71c.gif" border=0></a></td><td valign=top><p>Are you seeing inconsistent leadership and slow execution across your organization?&nbsp;</p> <p>SHRM&rsquo;s research confirms leadership and manager development as the top HR priority for 2026, yet many companies still develop leaders one at a time&mdash;leading to fragmented impact and missed opportunities.&nbsp;</p> <p>The SHRM Linkage Leadership Institute offers a&nbsp;cohort-based experience&nbsp;designed for teams.&nbsp;Attendees gain&nbsp;actionable insights, shared frameworks, and practical skills&nbsp;through immersive assessments and peer learning. When teams attend together, they return&nbsp;aligned, energized, and ready to drive results.&nbsp;</p> <p><strong>Why send a team?&nbsp;</strong></p> <ul> <li><strong>Accelerate execution:</strong>&nbsp;Cohorts return with a shared language and tools to implement change&nbsp;immediately.&nbsp;</li> <li><strong>Multiply ROI:</strong>&nbsp;Development scales across functions, not just individuals.&nbsp;</li> <li><strong>Build consistency:</strong>&nbsp;Teams create a unified, high-performing leadership pipeline.&nbsp;</li> </ul> <p><strong>82% of participants report improved team performance.&nbsp;</strong></p> <p>Close the leadership gap and see how cohort-based development delivers lasting impact&mdash;explore cohort registration and download the Team Attendance Guide for the SHRM Linkage Leadership Institute.&nbsp;</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_shrm71">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eisn05 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eisn05 Thu, 11 Jun 2026 00:01:13 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eisn05"><img src="http://img.tradepub.com/free/w_eisn05/images/w_eisn05c.gif" border=0></a></td><td valign=top><p>The private equity landscape has become more difficult to read. Sponsors and management teams are contending with shifting tax policy, rapid digital transformation, and heightened scrutiny on earnings quality and valuation.&nbsp; Compounding matters, teams are facing continued pressure to drive returns in a challenging fundraising environment made harder by geopolitical uncertainty.&nbsp;<br /> <br /> EisnerAmper's practical guide breaks down what matters most across the full investment lifecycle.<br /> <br /> Here's what's inside:</p> <ul> <li>Key tax developments: How the One Big Beautiful Bill Act (OBBBA) provisions, including restored 100% bonus depreciation, reinstated EBITDA-based interest limitations, and expanded Qualified Small Business Stock (QSBS) benefits, influence fund modeling, cash flow, and after-tax exit outcomes</li> <li>Digital risk and technology due diligence: Why AI adoption, vendor contracts, and data governance gaps are becoming material diligence and exit-readiness obstacles</li> <li>Financial due diligence: How modern financial due diligence goes beyond quality of earnings to validate cash conversion, revenue durability, and working capital dynamics before structure and pricing are finalized</li> <li>Valuation across the lifecycle: Why defensible, audit-ready valuations require continuous assessment, not just transaction-driven snapshots</li> </ul> <p>Whether evaluating a new platform, managing a portfolio company, or preparing for exit, this guide outlines the frameworks and questions sponsors should be asking right now.<br /> &nbsp;</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eisn05">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_ustx34 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_ustx34 Wed, 10 Jun 2026 23:01:12 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_ustx34"><img src="http://img.tradepub.com/free/w_ustx34/images/w_ustx34c.gif" border=0></a></td><td valign=top><p>Security leaders are drowning in vulnerabilities &mdash; yet the threats that matter most still slip through. Periodic scans and siloed tools create blind spots, leaving critical exposures undetected until damage is done.&nbsp;</p> <p>This whitepaper cuts through the noise with a practical framework for Continuous Threat Exposure Management (CTEM) &mdash; helping enterprises shift from reactive patching to continuous, risk-based decision-making.&nbsp;You'll&nbsp;learn how to map real attack paths, focus resources on&nbsp;what's&nbsp;business-critical, and&nbsp;validate&nbsp;that risks are&nbsp;eliminated, not just logged.&nbsp;</p> <p>Built for complex, regulated environments across Singapore, Hong Kong, and Malaysia &mdash; this is your roadmap to measurable cyber resilience.'&nbsp;</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_ustx34">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_bioq14 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_bioq14 Wed, 10 Jun 2026 19:01:09 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_bioq14"><img src="http://img.tradepub.com/free/w_bioq14/images/w_bioq14c.gif" border=0></a></td><td valign=top><p>Designing and executing an effective microbiological performance qualification program is critical to ensuring sterile manufacturing facilities operate in a sustained state of control and meet regulatory expectations. Eurofins BioPharma Product Testing experts present a practical, five-step framework for establishing a robust environmental monitoring performance qualification (EMPQ) that aligns facility design, risk-based monitoring, and disinfectant validation with global regulatory guidance. It addresses how EMPQ should be integrated with personnel practices, routine environmental monitoring, and data trending to proactively reduce contamination risk and support inspection readiness.</p> <p>This paper outlines how an integrated EMPQ strategy delivers measurable business and quality value by:</p> <ul> <li>Supporting regulatory compliance with USP, ISO, and PDA-aligned approaches</li> <li>Improving contamination control through risk-based sampling and trending</li> <li>Demonstrating disinfectant effectiveness using relevant environmental isolates</li> <li>Enabling continuous improvement rather than one-time qualification</li> <li>Strengthening long-term facility control, product quality, and patient safety</li> </ul><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_bioq14">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_boxi44 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_boxi44 Wed, 10 Jun 2026 18:50:13 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_boxi44"><img src="http://img.tradepub.com/free/w_boxi44/images/w_boxi44c.gif" border=0></a></td><td valign=top><p>Clinical study startup teams are held hostage by manual document workflows, slowing down progress on their missions. They&rsquo;re reviewing hundreds of CVs, protocols, financial disclosures, and forms while facing mounting pressure to activate sites faster. Every week spent on repetitive data entry and validation is another week delaying patient enrollment and revenue realization.</p> <p>Join Box life sciences experts as we demonstrate how Box Extract uses advanced OCR and agentic reasoning to automate the most time-consuming document workflows. You'll see real examples of biopharma teams reducing site qualification cycles from 4-6 weeks to 3-5 days while freeing clinical ops staff from repetitive work.</p> <p><strong>Topics we'll cover:</strong></p> <ul> <li><strong>Automate data extraction:</strong> Use AI-powered OCR to pull data from CVs, protocols, and site questionnaires</li> <li><strong>Maintain compliance:</strong> Reduce manual review time with built-in validation and confidence scoring</li> <li><strong>Scale operations: </strong>Process hundreds of documents simultaneously to qualify sites faster without increasing headcount</li> </ul><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_boxi44">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_cenj47 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_cenj47 Wed, 10 Jun 2026 18:20:12 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_cenj47"><img src="http://img.tradepub.com/free/w_cenj47/images/w_cenj47c.gif" border=0></a></td><td valign=top><p>SiteALERT&reg; is a customizable community practice analytics report that gives biopharma commercial teams visibility into real world physician and practice level treatment activity across oncology, retina, and urology market places. By understanding how therapies are being used in clinical settings, teams can better identify where opportunity exists and how to engage more effectively.</p> <p>Built on longitudinal clinical utilization data, SiteALERT highlights treatment patterns, drug regimen sequencing, and competitive use, providing actionable insight to support more focused sales and marketing execution.</p> <p><strong>This brochure highlights how SiteALERT helps teams:</strong></p> <ul> <li>Identify physicians actively managing relevant patient populations</li> <li>Understand real world treatment behavior and regimen sequencing</li> <li>Prioritize outreach based on observed clinical utilization, not assumptions</li> <li>Align sales and marketing efforts with how clinicians are practicing today</li> <li>Monitor adoption and performance across community practice networks</li> </ul> <p>Teams can also choose SiteALERT Pro, a hands-on data visualization tool offering pre-built, deeper analytic views of clinical utilization patterns. Delivered through a Power BI dashboard, it enables users to interactively explore data through intuitive visuals, drill-downs, and robust filtering options.</p> <p>Together, these solutions help optimize marketing spend and support behavior change by delivering the right tactics to the right physicians at the right time, grounded in real‑world clinical insight.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_cenj47">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_bluy111 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_bluy111 Wed, 10 Jun 2026 18:10:09 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_bluy111"><img src="http://img.tradepub.com/free/w_bluy111/images/w_bluy111c.gif" border=0></a></td><td valign=top><p>Turn compliance into a measurable business advantage.</p> <p>Pharma manufacturers and Contract Manufacturers (CDMOs) face increasing pressure to scale operations, reduce downtime, and maintain audit readiness, often while relying on disconnected or manual systems.</p> <p>The results show in inefficiencies, compliance risk, and limited visibility across assets and sites.</p> <p><strong>In this whitepaper, <em>Building the Business Case: Calculating the ROI of EAM/CMMS</em>, you&rsquo;ll learn how to quantify the value of modern asset management and build a case that stands up to internal and regulatory scrutiny.</strong></p> <p>You&rsquo;ll gain insights into:</p> <ul> <li>The true cost of manual and legacy asset management systems</li> <li>Nine clear indicators it&rsquo;s time to modernize your approach</li> <li>How to calculate ROI across productivity, downtime reduction, and compliance risk mitigation</li> <li>Practical strategies to align quality, maintenance, and operations teams</li> <li>What a purpose-built EAM/CMMS enables in regulated environments</li> </ul> <p>If you&rsquo;re evaluating how to improve asset performance while strengthening compliance, this guide will help you move from justification to action with a clear, defensible ROI framework.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_bluy111">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_catc133 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_catc133 Wed, 10 Jun 2026 18:01:09 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_catc133"><img src="http://img.tradepub.com/free/w_catc133/images/w_catc133c.gif" border=0></a></td><td valign=top><p>In today's competitive pharmaceutical landscape, drug developers are continually seeking innovative strategies to enhance bioavailability, improve patient compliance and expedite therapeutic outcomes. Pregastric absorption has emerged as a critical pathway to achieve these goals by enabling drugs to bypass gastrointestinal degradation and first-pass metabolism. This article explores the latest advancements in buccal and sublingual delivery systems, the impact of permeation enhancers and the role of PBPK modeling in predictive formulation design. The article also discusses how rapid-dissolving orally disintegrating tablets (ODTs) are influencing the development of patient-centric formulations, all with the goal of improving therapeutic efficacy and patient experience.</p> <p>Learn more about:</p> <ul> <li>Formulation strategies that improve pregastric drug absorption, including permeation enhancers and Zydis&reg; ODT</li> <li>Using PBPK modeling to simulate and predict oral cavity drug absorption, helping accelerate formulation timelines</li> <li>Designing patient-friendly ODTs that enhance pregastric delivery, improve taste, and increase ease of administration for better compliance</li> </ul><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_catc133">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_squd38 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_squd38 Wed, 10 Jun 2026 17:53:44 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_squd38"><img src="http://img.tradepub.com/free/w_squd38/images/w_squd38c.gif" border=0></a></td><td valign=top><p>In today&rsquo;s highly competitive food and beverage landscape, lasting concepts are rarely accidental. They are shaped by a clear point of view, disciplined execution, and the ability to evolve without losing what made them resonate in the first place.</p> <p>This article follows artist and entrepreneur Kelis as she spends time with the teams behind Miss Lily&rsquo;s, Harlem Hops, and Van Leeuwen&mdash;exploring how each has navigated the realities of building, refining, and sustaining a concept over time.</p> <p>Don&rsquo;t miss this valuable look at the decisions, trade-offs, and creative discipline required to turn a restaurant concept into something that continues to resonate and perform.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_squd38">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_moxj02 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_moxj02 Wed, 10 Jun 2026 16:50:10 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_moxj02"><img src="http://img.tradepub.com/free/w_moxj02/images/w_moxj02c.gif" border=0></a></td><td valign=top><p>Most agents don&rsquo;t lack strategy; they lack time. With marketing constantly pushed aside,&nbsp;consistency drops and opportunities are missed. This guide shows how to simplify your&nbsp;approach with systems that actually fit how real estate work gets done.&nbsp;</p> <p><strong>What You&rsquo;ll Gain from This Resource</strong></p> <ul> <li>Learn how to reduce time spent on marketing every week&nbsp;</li> <li>Build repeatable workflows across daily, listing, and long-term marketing&nbsp;</li> <li>Discover how to reuse and repurpose content instead of starting from scratch&nbsp;</li> <li>Streamline listing marketing with templates and faster execution&nbsp;</li> <li>Keep your marketing running while you&rsquo;re busy closing deals</li> </ul> <p><strong>Who Should Read This</strong></p> <ul> <li>Real estate agents &amp; teams&nbsp;</li> <li>Broker-owners &amp; principals&nbsp;</li> <li>Brokerage marketing leaders&nbsp;</li> <li>Professionals struggling to stay consistent with marketing&nbsp;</li> </ul> <p>The challenge? Marketing often becomes reactive, inconsistent, and time-consuming - costing you visibility and deals. This guide shows how to fix that with simple, scalable&nbsp;systems that work in the background.</p> <p><strong>Don&rsquo;t let marketing slow you down - build a system that works with you. Download&nbsp;now</strong></p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_moxj02">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_moxj01 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_moxj01 Wed, 10 Jun 2026 16:40:22 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_moxj01"><img src="http://img.tradepub.com/free/w_moxj01/images/w_moxj01c.gif" border=0></a></td><td valign=top><p>Most agents are sitting on thousands of contacts but only focus on the few actively&nbsp;<br /> transacting. Meanwhile, 5% of any database is ready to move at any given time,&nbsp;representing significant untapped revenue.&nbsp;</p> <p><strong>What You&rsquo;ll Gain from This Resource</strong></p> <ul> <li>Understand why most databases fail to generate consistent deals&nbsp;</li> <li>Identify who in your database is actually ready to transact&nbsp;</li> <li>Learn how to automate nurturing without losing personalization&nbsp;</li> <li>Discover how to capture more listings from your existing contacts&nbsp;</li> <li>See how top agents turn their database into a predictable pipeline&nbsp;</li> </ul> <p><strong>Who Should Read This</strong></p> <ul> <li>Real estate agents &amp; teams&nbsp;</li> <li>Broker-owners &amp; principals&nbsp;</li> <li>Agencies with large, underutilized databases&nbsp;</li> <li>Professionals looking to generate more listings without buying more leads&nbsp;</li> </ul> <p>The challenge? Most databases sit untouched - while competitors capture the&nbsp;opportunities inside them. Without the right systems, follow-up doesn&rsquo;t scale and high-intent prospects go unnoticed.</p> <p><strong>Don&rsquo;t let your database go cold - turn it into your biggest growth driver. Download&nbsp;now.</strong></p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_moxj01">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eurp32 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eurp32 Wed, 10 Jun 2026 16:40:10 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eurp32"><img src="http://img.tradepub.com/free/w_eurp32/images/w_eurp32c.gif" border=0></a></td><td valign=top><p>High turnover, constrained hiring, and growing execution demands are creating operational pressure across pharma and biotech R&amp;D. While staffing gaps are often treated as short-term resource challenges, the downstream impact on productivity, knowledge continuity, quality, and program execution can be far more significant, particularly in regulated environments where consistency and institutional knowledge matter.&nbsp;</p> <p>In this webinar, industry leaders will explore how workforce instability affects scientific operations and discuss emerging approaches to improve continuity, reduce disruption, and support more resilient R&amp;D execution.&nbsp;&nbsp;</p> <p>Topics will include:&nbsp;</p> <ul> <li>Why traditional temporary staffing models often struggle in regulated scientific environments&nbsp;&nbsp;</li> <li>The operational impact of turnover on productivity, quality, timelines, and compliance&nbsp;&nbsp;</li> <li>The role of continuity and embedded expertise in supporting long-term R&amp;D performance&nbsp;&nbsp;</li> <li>Strategies organizations are using to balance workforce flexibility with operational stability&nbsp;&nbsp;</li> <li>And more&nbsp;</li> </ul> <p>The session will conclude with a live interactive Q&amp;A. Don&rsquo;t miss out, register now!&nbsp;</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_eurp32">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw24 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw24 Wed, 10 Jun 2026 16:11:41 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw24"><img src="http://img.tradepub.com/free/w_harw24/images/w_harw24c.gif" border=0></a></td><td valign=top><p>Senior leaders are often told to focus on strategy and delegate execution, but some top-performing CEOs take a different approach. In this article, experts from Harvard Business School and Intuit reveal how hands-on leaders drive exceptional results by focusing on how work gets done and building systems that enable teams to excel. You will learn:</p> <ul> <li>Why effective CEOs stay deeply engaged in execution</li> <li>The five core principles that guide hands-on leaders &nbsp;</li> <li>How leaders use systems, coaching, and experimentation to drive scalable impact</li> </ul> <p>Download &ldquo;<strong>HBS Executive Insights: The Surprising Success of Hands-On Leaders</strong>&rdquo; and create a culture built for sustained high performance.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw24">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw23 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw23 Wed, 10 Jun 2026 16:11:29 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw23"><img src="http://img.tradepub.com/free/w_harw23/images/w_harw23c.gif" border=0></a></td><td valign=top><p>Leadership is often framed as the ability to direct and inspire, but the most effective leaders excel at something less visible: followership. In this article, experts including HBS professor Amy C. Edmondson explain&nbsp;that listening, learning, and adapting are now essential leadership skills in a complex, fast-changing world. You will learn:</p> <ul> <li>Why great leadership depends on mastering key followership behaviors</li> <li>Five core capabilities that define effective leaders</li> <li>How shifting from authority to adaptability helps leaders navigate complexity and disruption</li> </ul> <p>Download &ldquo;<strong>HBS Executive Insights: The Best Leaders Are Great Followers</strong>&rdquo; and learn how to cultivate the followership attributes that make outstanding leaders.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw23">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw16 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw16 Wed, 10 Jun 2026 16:11:17 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw16"><img src="http://img.tradepub.com/free/w_harw16/images/w_harw16c.gif" border=0></a></td><td valign=top><p>AI is transforming industries at an unprecedented pace, but many organizations still struggle to harness its full potential. In this article<strong>,</strong> Harvard Business School professor Hise O. Gibson outlines the three biggest challenges leaders encounter when adopting AI&mdash;and offers practical strategies to overcome them. You will learn:</p> <ul> <li>The key challenges in effectively implementing AI</li> <li>How to move from AI experimentation to lasting impact</li> <li>A roadmap for integrating AI responsibly and effectively</li> </ul> <p>Download &ldquo;<strong>HBS Executive Insights: Solving Three Common AI Challenges Companies Face</strong>&rdquo; and prepare to turn disruption into opportunity.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw16">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw15 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw15 Wed, 10 Jun 2026 16:11:05 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw15"><img src="http://img.tradepub.com/free/w_harw15/images/w_harw15c.gif" border=0></a></td><td valign=top><p>In today&rsquo;s volatile business environment, organizations need more than traditional managers&mdash;they need T-shaped leaders who combine deep expertise with the ability to collaborate across the enterprise. In this article<strong>,</strong> HBS professor Hise O. Gibson explains why success requires two types of T-shaped leaders. You will learn:</p> <ul> <li>Why you need both <em>Big-T</em> visionaries, who drive strategy and innovation, and <em>Little-T</em> tacticians, who ensure flawless execution</li> <li>How to identify, develop, and retain these leaders</li> <li>How having T-shaped leaders drives stronger pipelines and greater resilience</li> </ul> <p>Download &ldquo;<strong>HBS Executive Insights: Every Company Should Have These Leaders&mdash;or Develop Them if They Don&rsquo;t</strong>&rdquo; and make sure you have the right leaders in place.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw15">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw22 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw22 Wed, 10 Jun 2026 16:10:49 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw22"><img src="http://img.tradepub.com/free/w_harw22/images/w_harw22c.gif" border=0></a></td><td valign=top><p>Senior leaders are often told to focus on strategy and delegate execution, but some top-performing CEOs take a different approach. In this article, experts from Harvard Business School and Intuit reveal how hands-on leaders drive exceptional results by focusing on how work gets done and building systems that enable teams to excel. You will learn:</p> <ul> <li>Why effective CEOs stay deeply engaged in execution</li> <li>The five core principles that guide hands-on leaders &nbsp;</li> <li>How leaders use systems, coaching, and experimentation to drive scalable impact</li> </ul> <p>Download &ldquo;<strong>HBS Executive Insights: The Surprising Success of Hands-On Leaders</strong>&rdquo; and create a culture built for sustained high performance.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw22">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw21 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw21 Wed, 10 Jun 2026 16:10:37 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw21"><img src="http://img.tradepub.com/free/w_harw21/images/w_harw21c.gif" border=0></a></td><td valign=top><p>Leadership is often framed as the ability to direct and inspire, but the most effective leaders excel at something less visible: followership. In this article, experts including HBS professor Amy C. Edmondson explain&nbsp;that listening, learning, and adapting are now essential leadership skills in a complex, fast-changing world. You will learn:</p> <ul> <li>Why great leadership depends on mastering key followership behaviors</li> <li>Five core capabilities that define effective leaders</li> <li>How shifting from authority to adaptability helps leaders navigate complexity and disruption</li> </ul> <p>Download &ldquo;<strong>HBS Executive Insights: The Best Leaders Are Great Followers</strong>&rdquo; and learn how to cultivate the followership attributes that make outstanding leaders.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw21">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw20 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw20 Wed, 10 Jun 2026 16:10:24 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw20"><img src="http://img.tradepub.com/free/w_harw20/images/w_harw20c.gif" border=0></a></td><td valign=top><p>AI is transforming industries at an unprecedented pace, but many organizations still struggle to harness its full potential. In this article<strong>,</strong> Harvard Business School professor Hise O. Gibson outlines the three biggest challenges leaders encounter when adopting AI&mdash;and offers practical strategies to overcome them. You will learn:</p> <ul> <li>The key challenges in effectively implementing AI</li> <li>How to move from AI experimentation to lasting impact</li> <li>A roadmap for integrating AI responsibly and effectively</li> </ul> <p>Download &ldquo;<strong>HBS Executive Insights: Solving Three Common AI Challenges Companies Face</strong>&rdquo; and prepare to turn disruption into opportunity.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw20">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw19 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw19 Wed, 10 Jun 2026 16:10:12 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw19"><img src="http://img.tradepub.com/free/w_harw19/images/w_harw19c.gif" border=0></a></td><td valign=top><p>In today&rsquo;s volatile business environment, organizations need more than traditional managers&mdash;they need T-shaped leaders who combine deep expertise with the ability to collaborate across the enterprise. In this article<strong>,</strong> HBS professor Hise O. Gibson explains why success requires two types of T-shaped leaders. You will learn:</p> <ul> <li>Why you need both <em>Big-T</em> visionaries, who drive strategy and innovation, and <em>Little-T</em> tacticians, who ensure flawless execution</li> <li>How to identify, develop, and retain these leaders</li> <li>How having T-shaped leaders drives stronger pipelines and greater resilience</li> </ul> <p>Download &ldquo;<strong>HBS Executive Insights: Every Company Should Have These Leaders&mdash;or Develop Them if They Don&rsquo;t</strong>&rdquo; and make sure you have the right leaders in place.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_harw19">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct65 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct65 Wed, 10 Jun 2026 15:31:39 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct65"><img src="http://img.tradepub.com/free/w_auct65/images/w_auct65c.gif" border=0></a></td><td valign=top><p>AI is transforming ecommerce, with machines increasingly deciding which brands get seen and chosen. Most retailers call AI critical, but few use it beyond basic automation. Meanwhile, more than one in four consumers are already using chat-based AI to shop, making delivery, visibility, and execution more important than ever.</p> <p>We surveyed 8,000 consumers and 400 senior retail leaders to show how AI-driven delivery is creating a widening gap&mdash;and a measurable advantage for those leading the way.</p> <p>Will your delivery strategy keep pace, or will your brand fall behind? Download the report to stay ahead of the trends.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct65">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct64 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct64 Wed, 10 Jun 2026 15:31:30 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct64"><img src="http://img.tradepub.com/free/w_auct64/images/w_auct64c.gif" border=0></a></td><td valign=top><p>This data-driven session delivers&nbsp;<strong>actionable strategies&nbsp;</strong>from industry leaders who are successfully navigating today&rsquo;s ecommerce landscape. Whether you&rsquo;re adapting to shifting consumer behaviors, optimizing your marketplace presence, or leveraging AI for competitive advantage, you&rsquo;ll walk away with practical solutions to implement immediately.</p> <p>Key Takeaways:</p> <ul> <li><strong>Ecommerce Evolution:</strong>&nbsp;How consumers are reshaping their shopping behavior and how merchants are pivoting their strategies for 2025</li> <li><strong>Marketplace Strategy:</strong>&nbsp;Tactics to leverage marketplaces for rapid growth and expansion</li> <li>AI Advantage:&nbsp;The proven connection between technology adoption and online sales growth</li> <li><strong>Returns Management and Reverse Logistics:</strong> Practical strategies for turning returns from a cost center into a customer loyalty driver.</li> </ul><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct64">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct63 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct63 Wed, 10 Jun 2026 15:31:21 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct63"><img src="http://img.tradepub.com/free/w_auct63/images/w_auct63c.gif" border=0></a></td><td valign=top><p>We surveyed 8,000 consumers and 400 business executives to uncover key insights into the future of retail. Are you ready to adapt or be left behind? Download the report to stay ahead.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct63">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct62 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct62 Wed, 10 Jun 2026 15:31:11 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct62"><img src="http://img.tradepub.com/free/w_auct62/images/w_auct62c.gif" border=0></a></td><td valign=top><p>Get the insights you need now to avoid costly disruptions and protect your margins. Download the guide to identify blog spots and build a resilient, cross-border operation.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_auct62">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_celo07 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_celo07 Wed, 10 Jun 2026 15:30:57 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_celo07"><img src="http://img.tradepub.com/free/w_celo07/images/w_celo07c.gif" border=0></a></td><td valign=top><p>Every Life Sciences company wants to accelerate time to market, but Novo Nordisk is actually doing it. Join us to hear directly from Stephanie Bova, CVP R&amp;D at Novo Nordisk, on how the company is leveraging AI and Process Intelligence to accelerate drug development and improve operational execution across R&amp;D.</p> <p>As Stephanie notes, &quot;Without Process Intelligence, Enterprise AI at scale is hopeful thinking&quot;. Across Drug Discovery, Clinical Development, Regulatory Affairs, Quality, and Patient Safety, critical processes remain fragmented, manual, and difficult to orchestrate. This complexity limits the impact of AI initiatives and ultimately slows down patient outcomes.</p> <p>In this webinar, you will discover how to enable real transformation. We will explore how leading pharmaceutical organizations can leverage Process Intelligence to create real time visibility across systems, teams, and functions. Learn how to uncover bottlenecks, reduce cycle times, improve execution, and drive intelligent, data driven operations across the R&amp;D lifecycle.</p> <p>Attendees will learn:</p> <ol> <li>The Novo Nordisk Impact Story:&nbsp;A featured customer perspective on their R&amp;D transformation journey, including how they use AI to resolve bottlenecks, key lessons learned, and the business impact achieved.</li> <li>The Foundation for AI:&nbsp;Why process centric transformation and creating a &quot;digital twin&quot; of your operations is becoming the mandatory foundation for successful Enterprise AI adoption in R&amp;D</li> <li>Industry-Wide Applications:&nbsp;Real world examples of how leading pharma organizations are transforming with Process Intelligence and AI across the broader R&amp;D lifecycle.</li> <li>Live Demo:&nbsp;See how Celonis delivers end-to-end visibility, identifies bottlenecks, and enables AI-driven execution across a core Clinical Operations process.</li> </ol><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_celo07">Request Free!</a></td></tr></table> http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_genu02 http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_genu02 Wed, 10 Jun 2026 15:22:16 -0700 <table><tr><td valign=top><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_genu02"><img src="http://img.tradepub.com/free/w_genu02/images/w_genu02c.gif" border=0></a></td><td valign=top><p>Gene knock-out (KO) and knock-down (KD) are the gold standard methods for validating antibody specificity. Both approaches eliminate or silence the endogenous target protein to assess antibody binding and validate specificity. KO or KD validation is usually done at the gene level using qRT-PCR/qPCR or at the protein level using Western blotting, immunocytochemistry, or flow cytometry. However, validation using only one application has potential drawbacks.</p> <p>Download this article to learn more about the pros and cons of antibody validation methods and discover a new platform that uses all four in a multi-applicational validation approach.</p><br><br><a href="http://aboutmicrocontroller.tradepub.com/c/pubRD.mpl?sr=rss&_t=rss&qf=w_genu02">Request Free!</a></td></tr></table>